New frontiers in dementia: are we ready for disease modifying treatments?
New frontiers in dementia
| Timings | 4:00PM - 5:30PM |
| Location | , Online |
| CPD | 1 CPD point per hour of content, subject to peer approval |
| Non-Member | £34 |
|---|---|
| Consultant | £23 |
| Higher Trainee / SAS Doctor | £18 |
| Core Trainee / Subsidised / Retired | £10 |
| Medical Student / Foundation Doctor | £10 |
Event Information
Programme
We welcome Dr Bob Barber, Consultant Old Age Psychiatrist and Honorary Clinical Senior Lecturer Newcastle University, as our speaker for this webinar.
Dr Barber has an interest in clinical trials (including trials with monoclonal antibody therapies (bapineuzumab, crenezumab, solanezumab, gantenerumab, and aducanumab) as well as trials using novel small molecules, repurposed medications, cholinesterase inhibitors, and memantine. He is a member of Project Working Group for NHS Commissioning group to develop a NHS England Template Clinical Commissioning Statement for Lecanemab.
Other roles include TPD for Old Age Psychiatry and Finance Officer for Faculty, Chair of our Trust’s Medical Staff Committee, and I support our Trust’s International Fellowship Programme.
Previously he was NIHR-DeNDRoN Speciality Lead for North Cumbria and North-East, Industry Lead for Dementia (DeNDRoN), member of the NC-NE LCRN Executive Committee, Regional Advisor for the Northern Division and GMC Health Assessor.
Key learning points from this webinar: Understanding of the complexities of Alzheimer’s disease and current treatment landscape.
Terms and conditions
For further information, please contact:
Email: division.events@rcpsych.ac.uk
Contact Name: Division Events Team
Contact number: 0208 618 4240